| CDXC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CDXC shares outstanding history going back to 4/13/2016:
Also see: CDXC Market Cap History CDXC YTD Return |
CDXC Shares Outstanding History — ChromaDex Share Count Over Time
As of 3/3/2025 ChromaDex has 77.75 million CDXC shares outstanding. Investors often track the CDXC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CDXC share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 4/13/2016.
| CDXC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDXC Historical Shares Outstanding: +8.87% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CDXC Stock Price Chart |
| About Niagen Bioscience Inc |
| Chromadex Corp. is a global bioscience company. Co. is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Co.'s proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. We show 35 historical shares outstanding datapoints in our coverage of CDXC's shares outstanding history. Understanding the changing numbers of CDXC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CDXC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CDXC by allowing them to research CDXC shares outstanding history as well as any other stock in our coverage universe. |
| CDXC Current Stock Quote |
Quotes delayed 20 minutes  Free CDXC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CDXC Share Performance |
| Shares Outstanding Peers |
| ChromaDex (CDXC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CELC Shares Outstanding History CELG Shares Outstanding History CELL Shares Outstanding History CELU Shares Outstanding History CELZ Shares Outstanding History CEMI Shares Outstanding History CERC Shares Outstanding History CERE Shares Outstanding History CERS Shares Outstanding History CFMS Shares Outstanding History More Healthcare companies » |
CDXC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
